These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 1957197)

  • 1. [The anti-vitamins K].
    Taurand P; Taurand S
    Soins; 1991; (550-551):I-II. PubMed ID: 1957197
    [No Abstract]   [Full Text] [Related]  

  • 2. [Drug interactions with vitamin K antagonists].
    Thebault J; Tillement JP; Blatrix C
    Pathol Biol (Paris); 1973 Jun; 21(6):639-46. PubMed ID: 4581196
    [No Abstract]   [Full Text] [Related]  

  • 3. [The effect of vitamin K antagonists on the synthesis of vitamins by Lactobacillus arabinosus].
    CIMINO G
    Boll Soc Ital Biol Sper; 1953 Apr; 29(4):664-7. PubMed ID: 13105996
    [No Abstract]   [Full Text] [Related]  

  • 4. [Laboratory control of the effect of anti-vitamins K on blood coagulation].
    Langer B; Muraco B; Manasterski J; Bechara MJ; Sitrângulo Júnior C; Puech-Leão LE
    Rev Hosp Clin Fac Med Sao Paulo; 1984; 39(1):12-7. PubMed ID: 6484435
    [No Abstract]   [Full Text] [Related]  

  • 5. [Hemorrhagic complications of anti-vitamin K].
    Al-Hajje A; Calop N; Bosson JL; Calop J; Allenet B
    J Pharm Belg; 2009 Mar; (1):19-24. PubMed ID: 19391438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nature of the antagonism between vitamin K and coumarin antiboagulants.
    Lowenthal J; MacFarlane JA
    Thromb Diath Haemorrh; 1968 Jul; 19(3):611. PubMed ID: 5708143
    [No Abstract]   [Full Text] [Related]  

  • 7. High-performance liquid chromatography of K vitamins and their antagonists.
    Shearer MJ
    Adv Chromatogr; 1983; 21():243-301. PubMed ID: 6346810
    [No Abstract]   [Full Text] [Related]  

  • 8. [Duodenal hematomas during treatments with anti-vitamin K].
    Bloch F; Chousterman M; Petite JP
    Gastroenterol Clin Biol; 1980 Oct; 4(10):727-8. PubMed ID: 7439612
    [No Abstract]   [Full Text] [Related]  

  • 9. The pharmacology and therapeutics of vitamin K.
    Brace L
    Am J Med Technol; 1983 Jun; 49(6):457-63. PubMed ID: 6349360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Control of clotting factor biosynthesis by vitamin K.
    Suttie JW
    Fed Proc; 1969; 28(5):1696-701. PubMed ID: 4897771
    [No Abstract]   [Full Text] [Related]  

  • 11. [Pharmacodynamic and crystallin structure. Intermolecular relations and vitamin K activity].
    Gaultier J; Gay R; Hauw C
    Therapie; 1969; 24(4):643-56. PubMed ID: 5822004
    [No Abstract]   [Full Text] [Related]  

  • 12. [Thrombophlebitis--use of vitamin K antagonists].
    Schwieder G
    Internist (Berl); 1997 Mar; 38(3):261. PubMed ID: 9173050
    [No Abstract]   [Full Text] [Related]  

  • 13. [Vitamin K antagonists].
    D'Agostino F; D'Agostino M; Cambiè G; Cuccia A
    Riv Emoter Immunoematol; 1983; 30(1):1-31. PubMed ID: 6635478
    [No Abstract]   [Full Text] [Related]  

  • 14. Severe acquired deficiency of vitamin K-dependent factors and resistance to multiple vitamin K injections.
    Hanss M; Martoia R; Horellou MH; Samama M
    Thromb Haemost; 1989 Sep; 62(2):816. PubMed ID: 2814932
    [No Abstract]   [Full Text] [Related]  

  • 15. [Recommendations of the Hemostasis and Thrombosis Study Group. For better surveillance of anticoagulant therapy by anti-vitamin K agents].
    Nouv Rev Fr Hematol (1978); 1986; 28(5):331-2. PubMed ID: 3808944
    [No Abstract]   [Full Text] [Related]  

  • 16. [Recommendation of the Group for Studies on Hemostasis and Thrombosis. Toward better supervision of anticoagulant therapy by anti-vitamin K agents].
    Pathol Biol (Paris); 1986 Nov; 34(9):1035-6. PubMed ID: 3543814
    [No Abstract]   [Full Text] [Related]  

  • 17. [The use of Tissucol in oral surgery in problems of hemostasis].
    Garçon C; Cavaillon JP; Girard P
    Chir Dent Fr; 1986 Mar; 56(331):49-55. PubMed ID: 2940077
    [No Abstract]   [Full Text] [Related]  

  • 18. Compounding of vitamin A, D3, E and K3 supplements for cystic fibrosis patients: formulation and stability study.
    Huyghebaert N; De Beer J; Vervaet C; Remon JP
    J Clin Pharm Ther; 2007 Oct; 32(5):489-96. PubMed ID: 17875116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of the therapeutic education of patients using anti-vitamin K drugs in a cardiology/intensive care unit].
    Turc-Dessertine C
    Rech Soins Infirm; 2005 Mar; (80):59-75. PubMed ID: 15861918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Monitoring of treatment with vitamin K antagonists: a plea for "INR" (International Normalized Ratio)].
    Lecompte T; Samama MM
    Rev Prat; 1990 Feb; 40(6):563-5. PubMed ID: 2320884
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.